Oxybutynin Chloride Tablet
Product Images NDC 71335-1494

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 71335-1494). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Figure 1 Structure)

FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
This is likely a table comparing two different forms of a medication called Oybutynin. The parameters being compared include G (possibly a measure of drug concentration in the blood), Toa (unclear what this represents), AUC (area under the curve of drug concentration versus time in the blood), and UGy (another measure of drug concentration in the urine). However, the units and values seem to be incomplete or incorrectly -ed, so the information presented is not completely clear.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
The given text seems to be some chemical or scientific data which cannot be understood without proper context or reference. Thus, the useful description cannot be generated.*
FDA Label Image

Figure 2 (Figure 5 Figure2)

FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
This is a report of adverse events associated with Oxybutynin chloride involving various body systems such as infections, psychiatric disorders, nervous system disorders, eye disorders, gastrointestinal disorders, renal and urinary disorders. Some common adverse events reported include urinary tract infections, insomnia, nervousness, dizziness, dry mouth, constipation, nausea, dyspepsia, and urinary retention. However, the percentage of occurrences varies among different disorders.*
FDA Label Image
FDA Label Image

Label Image (Lbl713351494)

Label Image (Lbl713351494)
These are tablets of Oxybutynin Chloride 5mg packaged by Ergant Ranch. This product can be compared to Ditropan 5mg Tablet by KVK-TECH, INC. It comes in a light blue color and is shaped round with the inscription A84. The tablets come in a container that is light-resistant so the expiry date of MM/YY must be accurate. The tablets are stored at a room temperature range of 20°C-25°C (68°F-77°F). The NDC is 995091 and the package size is 30 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.